These results, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 guidance the principle of targeting ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. It can even be legally https://josephd173xpe8.59bloggers.com/profile